EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The eIF5-mimic protein 5MP1: a regulator of translation stringency and a multifaceted oncogene

Abhineet Banerjee, Grant Brooke, Susumu Ishiguro, Katsura Asano iD

The Journal of Biochemistry · 11.05.2026 · 179 (5) · 309-316

DOI: 10.1093/jb/mvag010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Biochemistry, online erschienen am 03.02.2026. Verfasst von Abhineet Banerjee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Cellular and Developmental Biology Program, Division of Biology, Kansas State University, Manhattan, 1717 Claflin Rd, Manhattan, KS 66506, …. Hauptthemen laut MEDLINE: Oncogenes, Protein Biosynthesis, DNA-Binding Proteins, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, JSPS KAKENHI, Kumamoto University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate initiation of eukaryotic translation is essential for proteome integrity, yet the process is intrinsically challenged by the potential use of non-AUG start codons. The eIF5-mimic protein 5MP1 (also known as BZW2) has emerged as a pivotal regulator that enhances stringency in start codon selection by competing with eIF5 and eIF2B for binding to eIF2 and eIF3. This competition suppresses non-AUG and repeat-associated non-AUG (RAN) translation and remodels the dynamics of the scanning preinitiation complex. Beyond its biochemical role, accumulating evidence since the first report of BZW1/5MP2 as an oncogene in 2009 indicates that 5MP1/2 proteins promote proliferation, metastasis and poor prognosis across diverse cancer types. However, the downstream effectors and mechanistic pathways linking translation control to tumorigenesis remain incompletely defined. This review summarizes current biochemical understanding of 5MP1 in translation initiation and synthesizes evidence supporting its tumor-promoting activities, outlining key questions and future directions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OncogenesProtein BiosynthesisDNA-Binding ProteinsNeoplasmsHumansAnimals

Stichwörter der Autor:innen

cancernon-AUG translationoncogenic signalingtranslation initiationtranslational control

Substanzen

BZW2 protein, humanDNA-Binding Proteins

Autor:innen und Institutionen

  • Molecular Cellular and Developmental Biology Program, Division of Biology, Kansas State University, Manhattan, 1717 Claflin Rd, Manhattan, KS 66506, USA.
  • Program of Biotechnology, Graduate School of Integrated Sciences for Life, Hiroshima University, 1-3-1 Kagamiyama, Higashi-Hiroshima, Hiroshima 739-8530, Japan.
  • Hiroshima Research Centre for Healthy Aging, Hiroshima University, 1-3-1 Kagamiyama, Higashi-Hiroshima, Hiroshima 739-8530, Japan.

ORCID-Profile: Katsura Asano

Förderung

  • NIGMS NIH HHS
  • JSPS KAKENHI
  • Kumamoto University
  • IMEG
  • Joint Usage/Research Center for Developmental Medicine
  • NSF
  • NIH HHS
  • NIH

Zitieren

APA

Banerjee, A., Brooke, G., Ishiguro, S., & Asano, K. (2026). The eIF5-mimic protein 5MP1: a regulator of translation stringency and a multifaceted oncogene. The Journal of Biochemistry, 179(5), 309-316. https://doi.org/10.1093/jb/mvag010

Vancouver

Banerjee A, Brooke G, Ishiguro S, Asano K. The eIF5-mimic protein 5MP1: a regulator of translation stringency and a multifaceted oncogene. The Journal of Biochemistry. 2026;179(5):309-316. doi:10.1093/jb/mvag010

BibTeX
@article{Banerjee2026,
  author = {Banerjee, Abhineet and Brooke, Grant and Ishiguro, Susumu and Asano, Katsura},
  title = {The eIF5-mimic protein 5MP1: a regulator of translation stringency and a multifaceted oncogene},
  journal = {The Journal of Biochemistry},
  year = {2026},
  volume = {179},
  number = {5},
  pages = {309--316},
  doi = {10.1093/jb/mvag010}
}
Kostenlos starten →